Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Colon cancer (CC) pathological staging fails to accurately predict recurrence, and to date, no gene expression signature has proven reliable for prognosis stratification in clinical practice, perhaps because CC is a heterogeneous disease. The aim of this study was to establish a comprehensive molecular classification of CC based on mRNA expression profile analyses. METHODS AND FINDINGS: Fresh-frozen primary tumor samples from a large multicenter cohort of 750 patients with stage I to IV CC who underwent surgery between 1987 and 2007 in seven centers were characterized for common DNA alterations, including BRAF, KRAS, and TP53 mutations, CpG island methylator phenotype, mismatch repair status, and chromosomal instability status, and were screened with whole genome and transcriptome arrays. 566 samples fulfilled RNA quality requirements. Unsupervised consensus hierarchical clustering applied to gene expression data from a discovery subset of 443 CC samples identified six molecular subtypes. These subtypes were associated with distinct clinicopathological characteristics, molecular alterations, specific enrichments of supervised gene expression signatures (stem cell phenotype-like, normal-like, serrated CC phenotype-like), and deregulated signaling pathways. Based on their main biological characteristics, we distinguished a deficient mismatch repair subtype, a KRAS mutant subtype, a cancer stem cell subtype, and three chromosomal instability subtypes, including one associated with down-regulated immune pathways, one with up-regulation of the Wnt pathway, and one displaying a normal-like gene expression profile. The classification was validated in the remaining 123 samples plus an independent set of 1,058 CC samples, including eight public datasets. Furthermore, prognosis was analyzed in the subset of stage II-III CC samples. The subtypes C4 and C6, but not the subtypes C1, C2, C3, and C5, were independently associated with shorter relapse-free survival, even after adjusting for age, sex, stage, and the emerging prognostic classifier Oncotype DX Colon Cancer Assay recurrence score (hazard ratio 1.5, 95% CI 1.1-2.1, p = 0.0097). However, a limitation of this study is that information on tumor grade and number of nodes examined was not available. CONCLUSIONS: We describe the first, to our knowledge, robust transcriptome-based classification of CC that improves the current disease stratification based on clinicopathological variables and common DNA markers. The biological relevance of these subtypes is illustrated by significant differences in prognosis. This analysis provides possibilities for improving prognostic models and therapeutic strategies. In conclusion, we report a new classification of CC into six molecular subtypes that arise through distinct biological pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Summary of the main characteristics of the six subtypes. Symbols correspond to the relative frequency within the subtype (o: very low frequencies [∼0%]; +++: very high frequencies; +/++: intermediate frequencies), and arrows indicate significant enrichment of subtype up- and down-regulated genes in most of the pathways of the given category. EMT, epithelial–mesenchymal transition; SC, stem cell; Wnt pw, Wnt pathway.](https://figures.cochat.ai/paper-figures/d9e6ea3312ee4d83b17b55c403c90fdb/gene-expression-classification-of-colon-cancer-into-molecular-subtypes-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Again, the MEKi bypass resistance was strongly correlated with the SRC activation/dasatinib sensitivity, the EMT-like stemness and the CMS4 subtype (see Fig. 6 and Fig. 7 as well as Additional File 3_Fig S5 and Fig S6).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Similar results were seen in Marisa 458 CMS1-4 CRC tumors (Fig. 8d).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116 · cited 1×
“To obtain a robust classification, we used a consensus unsupervised approach [22] implemented in the R package ConsensusClusterPlus.”
MethodWeisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Research works printed but not linked: 1
- American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven.
Cited by
Items 901–1,000 of 1,001
Lu, H., Yang, D., Shi, Y., Chen, K., Li, P., Huang, S., Cui, D., Feng, Y., Wang, T., Yang, J., et al. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114466 · Cited by 7
Scott, P. M., Wang, S., Onyeaghala, G. C., Pankratz, N., Starr, T. K., & Prizment, A. E. (2023) · Cancers · doi:10.3390/cancers15030989 · Cited by 7
Machine learning-based meta-analysis of colorectal cancer and inflammatory bowel disease
Sardari, A., & Usefi, H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290192 · Cited by 7
Yang, W., Li, Z., Li, Y., He, W., & Yan, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c05893 · Cited by 7
Gu, Y., Li, C., Yan, Y., Ming, J., Li, Y., Xiang, C. J., & Wang, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111830 · Cited by 7
Razumovskaya, A. V., Silkina, M. O., Poloznikov, A. A., Kulagin, T., Raigorodskaya, M. P., Gorban, N. A., Kudryavtseva, A. V., Fedorova, M., Alekseev, B. Y., Tonevitsky, A., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1531175 · Cited by 7
Kaprio, T., Hagström, J., Kasurinen, J., Gkekas, I., Edin, S., Beilmann‐Lehtonen, I., Strigård, K., Palmqvist, R., Gunnarson, U., Böckelman, C., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-03618-z · Cited by 7
Genomic approach to translational studies in colorectal cancer
Cheasley, D. A., Jorissen, R. N., Liu, S., Tan, C. W., Love, C. G., Palmieri, M., & Sieber, O. M. (2018) · Translational Cancer Research · doi:10.21037/4524 · Cited by 7
Matsuyama, T., Kandimalla, R., Ishikawa, T., Takahashi, N., Yamada, Y., Yasuno, M., Kinugasa, Y., Hansen, T. F., Fakih, M., Uetake, H., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33129 · Cited by 7
Fontana, E., Nyamundanda, G., Cunningham, D., Tu, D., Cheang, M. C. U., Jonker, D. J., Siu, L. L., Sclafani, F., Eason, K., Ragulan, C., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00050 · Cited by 7
Huang, X., Liu, J., Liu, H., Mo, X., Meng, Y., Zhang, L., Deng, Y., Zhang, Y., & Tang, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.595182 · Cited by 7
Identification of a two-gene prognostic model associated with cytolytic activity for colon cancer
Jiang, X., Jiang, Z., Xiang, L., Chen, X., Wu, J., & Jiang, Z. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01782-6 · Cited by 7
Garate, J., Maimó‐Barceló, A., Bestard-Escalas, J., Fernández, R., Pérez‐Romero, K., Martínez, M. A. O., Payeras, M. A., Lopez, D. H., Fernández, J. A., & Barceló‐Coblijn, G. (2021) · Cancers · doi:10.3390/cancers13061350 · Cited by 7
Patil, A. R., Leung, M., & Roy, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115564 · Cited by 7
Liu, Y., & Zhou, W. L. (2022) · Bioengineered · doi:10.1080/21655979.2022.2044275 · Cited by 7
Zhong, M., Huang, Z.-P., Wang, X., Cai, D., Li, C., Gao, F., Wu, X., & Wang, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.902974 · Cited by 7
Prasad, H., Mandal, S., Mathew, J. K. K., Cherukunnath, A., Duddu, A. S., Banerjee, M., Ramani, H., Bhat, R., Jolly, M. K., & Visweswariah, S. S. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0606 · Cited by 7
Molecular Taxonomy and Tumourigenesis of Colorectal Cancer
Biswas, S., Holyoake, D., & Maughan, T. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.11.001 · Cited by 7
Royse, K. E., Liang, C., Berger, D. H., Ittmann, M., El‐Serag, H. B., Balentine, C. J., Graham, D. Y., Richardson, P., Rumbaut, R. E., Shen, X. Y., et al. (2017) · PubMed · Cited by 7
Daemen, A., Udyavar, A. R., Sandmann, T., Li, C., Bosch, L. J. W., O’Gorman, W. E., Li, Y., Au‐Yeung, A., Takahashi, C., Kabbarah, O., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0262198 · Cited by 7
Recent advances in computational epigenetics
Ruskin, H. J., & Barat, A. (2017) · Advances in Genomics and Genetics · doi:10.2147/agg.s115524 · Cited by 7
Zhang, B., Wang, L., Liu, Z., Shao, B., Jiang, W., & Shu, P. (2020) · Medicine · doi:10.1097/md.0000000000020617 · Cited by 7
Zhang, Z., Wu, Q., Zhu, D., He, G., Feng, Q., & Xu, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107243 · Cited by 7
Liu, X., Qin, J., Nie, J., Sun, H., Pan, Y., & Wang, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.948920 · Cited by 6
Kasurinen, J., Hagström, J., Kaprio, T., Jalkanen, S., Salmi, M., Böckelman, C., & Haglund, C. H. (2023) · Cancers · doi:10.3390/cancers15153871 · Cited by 6
MOXD1 is a lineage-specific gene and a tumor suppressor in neuroblastoma
Fredlund, E., Andersson, S., Hilgert, E., Monferrer, E., Álvarez‐Hernán, G., Karakaya, S., Loontiens, S., Bek, J. W., Gregor, T., Lecomte, E., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado1583 · Cited by 7
Bayrak, Ç. S., Forst, C. V., Jones, D. R., Gresham, D., Pushalkar, S., Wu, S., Vogel, C., Mahal, L. K., Ghedin, E., Ross, T. M., et al. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110333 · Cited by 6
Zhou, L., Yu, L., Liao, M., Peng, T., Zhang, L., Han, C., Li, Y., & Zhang, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-02435-0 · Cited by 6
Douget, J.-E. L., Jacob, P. M., Lepage, C., Gallois, C., Sroussi, M., de Reyniès, A., Cazelles, A., Gonzalez, D., Maussion, C., Bouché, O., et al. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100877 · Cited by 6
Self-citationAccelerating Therapeutic Development through Innovative Trial Design in Colorectal Cancer
Lam, M. S., Loree, J. M., Lima, A. A. P., Chun, Y. S., & Kopetz, S. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0524-2 · Cited by 6
Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer
Lecointre, C., Fourgous, E., Montarras, I., Kerneur, C., Simon, V., Boublik, Y., Bonenfant, D., Robert, B., Martineau, P., & Roche, S. (2022) · Cancers · doi:10.3390/cancers14122981 · Cited by 6
Dai, Z., Peng, X., Guo, Y., Shen, X., Ding, W., Fu, J., Liang, Z., & Song, J. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04070-6 · Cited by 6
Ling, Y., Wang, Y., Cao, C., Feng, L., Zhang, B., & Li, S. (2022) · Aging · doi:10.18632/aging.204379 · Cited by 6
Man, Y., Xin, D., Ji, Y., Liu, Y., Kou, L., & Jiang, L. (2024) · Discover Oncology · doi:10.1007/s12672-024-00916-2 · Cited by 6
Identification of unique rectal cancer-specific subtypes
Kısakol, B., Matveeva, A., Salvucci, M., Kel, A. E., McDonough, E., Ginty, F., Longley, D. B., & Prehn, J. H. M. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02656-0 · Cited by 6
Zhu, Z., Li, J., Fa, Z., Xu, X., Wang, Y., Zhou, J., & Xu, Y. (2024) · BMC Cancer · doi:10.1186/s12885-024-12996-y · Cited by 6
HIC1 Expression Distinguishes Intestinal Carcinomas Sensitive to Chemotherapy
Janečková, L., Kolář, M., Švec, J., Lanikova, L., Pospíchalová, V., Dibus, N., Vojtěchová, M., Šloncová, E., Strnad, H., & Kořínek, V. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.01.005 · Cited by 6
Zimmitti, G., Panettieri, E., Ardito, F., Mele, C., Vellone, M., Rosso, E., Nuzzo, G., & Giuliante, F. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.09.011 · Cited by 6
Dysregulation of core circadian genes, BMAL1 and CLOCK, in colorectal cancer
Sahar, N.-E., Qadir, J., Riaz, S. K., Sultan, A., Arif, A., & Malik, M. F. A. (2021) · Biological Rhythm Research · doi:10.1080/09291016.2021.1940623 · Cited by 6
Dong, Y., Shang, T., Ji, H., Zhou, X., & Chen, Z. J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.685371 · Cited by 6
Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
Li, Y., Li, D., Chen, Y., Lu, Y., Zhou, F., Li, C., Zeng, Z., Cai, W., Lin, L., Li, Q., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.727752 · Cited by 6
Xiao-Cheng, W., Yang, T., Qian, L., Zhang, D., & Yang, H. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s325511 · Cited by 6
SSCS: A Stage Supervised Subtyping System for Colorectal Cancer
Zhao, L., & Pan, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9121815 · Cited by 6
Qin, Y., Li, M., Lin, Q., Pan, X., Liang, Y., Huang, Z., Liu, Z., Huang, L., & Fang, M. (2022) · Cancer Control · doi:10.1177/10732748221121382 · Cited by 6
Shafiee, S., Jagtap, J. M. M., Zayats, M., Epperlein, J. P., Banerjee, A., Geurts, A. M., Flister, M. J., Zhuk, S. M., & Joshi, A. (2023) · Cancers · doi:10.3390/cancers15051460 · Cited by 6
Yu, L., Wang, L., Sun, J., Zhou, X., Hu, Y., Hu, L., He, Y., Lin, C., Chen, J., Xu, X., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.885930 · Cited by 6
Principles of risk assessment in colon cancer: immunity is key
Hijazi, A., & Galon, J. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2347441 · Cited by 6
Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cells
Burov, A. V., Grigorieva, E., Lebedev, T. D., Vedernikova, V., Попенко, В. И., Astakhova, T., Leonova, O. G., Spirin, P., Prassolov, V., Карпов, В. Л., et al. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1351641 · Cited by 6
SERPINC1 , a new prognostic predictor of colon cancer, promote colon cancer progression through EMT
Le, Z., Chen, S., Feng, Y., Lu, W., & Liu, M. (2024) · Cancer Reports · doi:10.1002/cnr2.2079 · Cited by 6
Immune therapy in colorectal cancer
Lapeyre-Prost, A., Terme, M., Pernot, S., Marcheteau, E., Pointet, A., Voron, T., Tartour, É., & Taïeb, J. (2017) · Colorectal Cancer · doi:10.2217/crc-2017-0002 · Cited by 6
Molecular classification of colorectal cancer using the gene expression profile of tumor samples
Rashid, M., Vishwakarma, R. K., Deeb, A., Hussein, M., & Aziz, M. A. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219850788 · Cited by 6
Simple classifiers for molecular subtypes of colorectal cancer
Kim, W. G., Kim, J. Y., & Park, D. Y. (2017) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2017.11.007 · Cited by 6
A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the Clinic
Salvucci, M., Rahman, A., Resler, A. J., Udupi, G. M., McNamara, D. A., Kay, E. W., Laurent‐Puig, P., Longley, D. B., Johnston, P. G., Lawler, M., et al. (2019) · JCO Clinical Cancer Informatics · doi:10.1200/cci.18.00056 · Cited by 6
Self-citationCardone, C., Martinelli, E., Troiani, T., Sforza, V., Avallone, A., Nappi, A. G., Montesarchio, V., Andreozzi, F., Biglietto, M., Calabrese, F., et al. (2019) · ESMO Open · doi:10.1136/esmoopen-2019-000519 · Cited by 6
Li, J., Zeng, Z., Chen, J., Liu, X., Jiang, X., Sun, W., Luo, Y., Ren, J., Gong, Y. Q., & Xie, C. (2020) · Journal of Cancer · doi:10.7150/jca.49262 · Cited by 6
A systematic comparison of data- and knowledge-driven approaches to disease subtype discovery
Rintala, T., Federico, A., Latonen, L., Greco, D., & Fortino, V. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab314 · Cited by 6
A Robust Procedure for Machine Learning Algorithms Using Gene Expression Data
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac122.24222439 · Cited by 6
Hidden patterns of gene expression provide prognostic insight for colorectal cancer
Kim, D., & Cho, K. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00520-y · Cited by 6
Ragulan, C., Eason, K., Fontana, E., Nyamundanda, G., Patil, Y., Poudel, P., Lawlor, R. T., Rio, M. D., Koo, S., Tan, W. S., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/174847 · Cited by 6
Molecular portraits of colorectal cancer morphological regionsPreprint
Budínská, E., Hrivňáková, M., Ivković, T. C., Mądrzyk, M., Nenutil, R., Bencsiková, B., Tukmachi, D. A., Ruckova, M., Dubská, L. Z., Slabý, O., et al. (2023) · eLife · doi:10.7554/elife.86655.2 · Cited by 7
Gan, T., Wei, X., Xing, Y., & Hu, Z. (2024) · Biomedical Engineering and Computational Biology · doi:10.1177/11795972241293516 · Cited by 5
Bayat, A., Sharafshah, A., Sefat, F., Rahimzadegan, M., Raad, M., & Lewandrowski, K. (2024) · Current Aging Science · doi:10.2174/0118746098348122241024061610 · Cited by 5
Huang, Z., Zheng, Y., Wang, W., Zhou, W., Zhang, Y., Chen, W., Zhang, X., Jin, X., & Yin, J. (2024) · Communications Biology · doi:10.1038/s42003-024-07238-7 · Cited by 5
Ji, C., Ding, L., Jia, F., Zhang, Z., & Long, C. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s491211 · Cited by 5
Yang, M., Nebozhyn, M., Schell, M. J., Gandhi, N. S., Pflieger, L. T., Loboda, A. P., Pledger, W. J., Soundararajan, R., Maurin, M. M., Wang, H., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13829-2 · Cited by 5
Hybrid Attentive Graph Neural Networks for time series gene expression clustering
Giovanoudi, E., & Rafailidis, D. (2025) · Expert Systems with Applications · doi:10.1016/j.eswa.2025.127136 · Cited by 5
Identification of endoplasmic reticulum stress-related genes as prognostic markers in colon cancer
Xu, W., Li, W., Kuai, D., Li, Y., Sun, W., Liu, X., & Xu, B. (2025) · Cancer Biology & Therapy · doi:10.1080/15384047.2025.2458820 · Cited by 5
Wang, J., Gao, C., Zhang, J., Luo, H., Dai, S., & Wang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1547794 · Cited by 5
Guo, X., He, X., Chen, W., Zhou, J., Lyu, Z., Li, Z., & Li, Y. Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-02770-6 · Cited by 5
Predictive and Prognostic Biomarkers of Recurrence in Locoregional Colorectal Cancer
Cendra, A. S., Pekarek, L., Ospino, L. R., Dbouk, Y., Chnaiker, S., Luengo, A., Villamor, T., Corralo, A., Pedrejón, B. I., Pekarek, T., et al. (2025) · Journal of Cancer · doi:10.7150/jca.111828 · Cited by 5
ERO1A-positive tumor epithelial cells in colorectal cancer progression: a multi-omics perspective
Hu, S., Lou, J., Chen, Y., Ding, M., Qin, J., Nie, J., Li, Y., Liu, Z., Xu, M., Sun, H., et al. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02184-z · Cited by 5
Fang, J., Zhu, Q., Hong, B., Li, X., & Wang, H. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03996-4 · Cited by 5
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation
Kanellos, G., Giacomelli, C., Raven, A., Vlahov, N., Jin, H., Herviou, P., Malla, S. B., Nasreddin, N., Centeno, P. P., Alexandrou, C., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02408-7 · Cited by 5
Li, M., Su, Y., Tang, Y., Lee, Y., & Tian, W. (2026) · Genome biology · doi:10.1186/s13059-026-03942-1 · Cited by 5
Xia, P., Qu, Y., Liu, Q., Zhu, M., Huang, B., Wu, W., Li, K., Wu, L., Zhang, R., Lv, Y., et al. (2026) · Theranostics · doi:10.7150/thno.126314 · Cited by 5
Iglesias, M., Badia-Ramentol, J., Martínez‐Ciarpaglini, C., Linares, J., Tarazona, N., Mulet-Margalef, N., Tornero-Piñero, P., Sallent-Aragay, A., Recort-Bascuas, A., Gibert, J., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-336804 · Cited by 6
Theilhaber, J., Chiron, M., Dreymann, J., Bergstrom, D. A., & Pollard, J. R. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03655-7 · Cited by 5
Alnabulsi, A., Wang, T., Pang, W., Ionescu, M., Craig, S. G., Humphries, M. P., McCombe, K. D., Salto‐Tellez, M., Alnabulsi, A., & Murray, G. I. (2022) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.258 · Cited by 5
Xu, G., Mo, Y., Li, J., Wei, Q., Zhou, F., & Chen, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1136875 · Cited by 5
Rao, W., Zhang, Q., Dai, X., Yang, Y., Zhang, L., Kuang, X., Xiao, H., Zhu, J., Xiong, Y., Wang, D., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-98088-8 · Cited by 5
Liu, G., Zhu, Z., Xing, Y., Meng, H., Shinwari, K., Xiao, N., & Liu, G. (2025) · Hereditas · doi:10.1186/s41065-025-00487-4 · Cited by 5
Xiao, Y., Zhang, G., Xiao, Y., Li, Z., Liu, H., He, L., & Li, J. (2025) · ONCOLOGIE · doi:10.1515/oncologie-2025-0248 · Cited by 5
Qiu, M., Lan, C., Xia, Z., Wu, H., Wang, Z., Ji, W., & Lin, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148341 · Cited by 5
Benard, B. A., Lalgudi, C. K., Ilerten, I., Wang, R. H., & Gentles, A. J. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1215 · Cited by 5
Zhang, Q., Feng, Z., Zhang, Y., Shi, S., Zhang, Y., & Ren, S. (2021) · BioMed Research International · doi:10.1155/2021/6057948 · Cited by 5
Jongeneel, G., Greuter, M. J. E., Kunst, N., van Erning, F. N., Koopman, M., Medema, J. P., Vermeulen, L., IJzermans, J. N. M., Vink, G. R., Punt, C. J. A., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0078 · Cited by 5
Bourdakou, M. M., Spyrou, G. M., & Kolios, G. C. (2021) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20295 · Cited by 5
Predictive “omic” biomarkers of drug response: Colorectal cancer as a model
Mini, E., Landini, I., Paolo, A. D., Ravegnini, G., Saponara, S., Frosini, M., Lapucci, A., & Nobili, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90190-1.00002-0 · Cited by 5
Xue, Z., Yang, S., Luo, Y., He, M., Qiao, H., Peng, W., Tong, S., Hong, G., & Guo, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.993726 · Cited by 5
Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers
Yang, L., Wei, J., Ma, X., Cheng, R., Zhang, H., & Jin, T. (2023) · Oncology · doi:10.1159/000533421 · Cited by 5
Knapen, D. G., Lopez, S. H., de Groot, D. J. A., de Haan, J. J., de Vries, E. G. E., Dienstmann, R., de Jong, S., Bhattacharya, A., & Fehrmann, R. S. N. (2024) · Communications Medicine · doi:10.1038/s43856-024-00504-z · Cited by 5
Zeng, Q., Lin, H. L., Hong, Q., Wang, G.-C., Xue, X., Fang, Y., & Liu, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33794 · Cited by 5
A Novel CRISPR/Cas9-mediated Mouse Model of Colon Carcinogenesis
Kashima, H., Fischer, A. D., Veronese-Paniagua, D., Gazit, V. A., Ma, C., Yan, Y., Levin, M. S., Madison, B., & Rubin, D. C. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101390 · Cited by 5
Dong, W., Li, S., Tang, W., Sun, Q., Zhu, P., Wang, M., & Xu, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-89521-z · Cited by 5
A Model of Butyrate Activity and Resistance in CRC
Bordonaro, M. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70656 · Cited by 5
CAsubtype: An R Package to Identify Gene Sets Predictive of Cancer Subtypes and Clinical Outcomes
Kong, H., Tong, P., Zhao, X., Sun, J., & Li, H. (2017) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-016-0198-z · Cited by 5
Colorectal Cancer Subtypes – The Current Portrait
Jordan, P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-02771-1_1 · Cited by 5
Bayesian Error Analysis for Feature Selection in Biomarker Discovery
pour, A. F., & Dalton, L. A. (2019) · IEEE Access · doi:10.1109/access.2019.2932622 · Cited by 5
Lv, X., Li, X., Chen, S., Zhang, G., Li, K., Wang, Y., Duan, M., Zhou, F., & Liu, H. (2023) · Genes · doi:10.3390/genes14061138 · Cited by 5
Clasificación molecular del carcinoma de colon y recto. Una revisión corta
Lino-Silva, L. S., León-Takahashi, A. M., López-Basave, H. N., Padilla-Rosciano, A. E., Miranda-Dévora, G., García, M. G., & Salcedo‐Hernández, R. A. (2018) · Gaceta Médica de México · doi:10.24875/gmm.m18000195 · Cited by 5
Metadata
- Authors
- Marisa, L., de Reyniès, A., Duval, A., Selves, J., Gaub, M. P., Vescovo, L., Etienne-Grimaldi, M.-C., Schiappa, R., Guenot, D., Ayadi, M., Kirzin, S., Chazal, M., Fléjou, J.-F., Benchimol, D., Berger, A., Lagarde, A., Pencreach, E., Piard, F., Elias, D., Parc, Y., Olschwang, S., Milano, G., Laurent-Puig, P., & Boige, V.
- Affiliations
- Inserm (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- La Ligue Contre le Cancer (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Hôpital Européen Georges-Pompidou (FR)
- CHU Dijon Bourgogne (FR)
- Institut Gustave Roussy (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-21
- Volume
- 10
- Issue
- 5
- Pages
- e1001453
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC3660251
- OpenAlex
- W2154941270
- Cited by
- 1,507
- References
- 40
- Citations by year
- 2026: 84 · 2025: 111 · 2024: 108 · 2023: 142 · 2022: 145 · 2021: 194 · 2020: 131 · 2019: 126 · 2018: 131 · 2017: 108 · 2016: 90 · 2015: 74 · 2014: 53 · 2013: 8
- FWCI
- 56.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- American Association for Cancer Research
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- colon cancer, molecular subtypes, gene expression signatures, mismatch repair deficiency, chromosomal instability, KRAS mutation, BRAF mutation, TP53 mutation, CpG island methylator phenotype, Wnt signaling, relapse-free survival, prognosis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Colonic Neoplasms, Female, France, Genetic Testing, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, RNA, Messenger, Time Factors, Biomarkers, Tumor, Reproducibility of Results, Gene Expression Regulation, Neoplastic, Multivariate Analysis, Cluster Analysis, Chi-Square Distribution, Logistic Models, Proportional Hazards Models, Risk Assessment, Genetic Predisposition to Disease, Gene Expression Profiling, Kaplan-Meier Estimate, Young Adult, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.